Knygos.lt klubas Knygos.lt nariams
42,92 €
-15%
Įprastai
50,49 €
Analysis of financial performance of selected pharmaceutical companies of india
Analysis of financial performance of selected pharmaceutical companies of india
Knygos.lt klubas Knygos.lt nariams
42,92 €
-15%
Įprastai
50,49 €
  • Išsiųsime per 12–18 d.d.
GLOBAL PHARMACEUTICAL INDUSTRYThe global pharmaceutical industry is worth US$ 300 billion a year, a figure projected to grow within three years to US$ 400 billion. The 10 biggest drugfirms control more than one-third of this market, many with annual revenue of more than US$ 10 billion and profit margins of about 30%. Six are based in the sUSA and four are based in Europe. North and South America, Europe, and Japan are expected to continue to account for a complete 85% of the global pharmaceuti…

Analysis of financial performance of selected pharmaceutical companies of india (el. knyga) (skaityta knyga) | knygos.lt

Atsiliepimai

Aprašymas

GLOBAL PHARMACEUTICAL INDUSTRY

The global pharmaceutical industry is worth US$ 300 billion a year, a figure projected to grow within three years to US$ 400 billion. The 10 biggest drug


firms control more than one-third of this market, many with annual revenue of more than US$ 10 billion and profit margins of about 30%. Six are based in the sUSA and four are based in Europe. North and South America, Europe, and Japan are expected to continue to account for a complete 85% of the global pharmaceutical market well into the 21st century. At present, businesses spend one-third of their sales income on selling their goods - nearly double what they spend on research and growth.

Knygos.lt klubas
Knygos.lt nariams
42,92 €
-15%
Įprastai
50,49 €
Kaina registruotiems pirkėjams
Prisijunkite ir už šią prekę
gausite 0,43 Knygų Eurų!?
Išsiųsime per 12–18 d.d.
Įsigykite dovanų kuponą
Daugiau

GLOBAL PHARMACEUTICAL INDUSTRY

The global pharmaceutical industry is worth US$ 300 billion a year, a figure projected to grow within three years to US$ 400 billion. The 10 biggest drug


firms control more than one-third of this market, many with annual revenue of more than US$ 10 billion and profit margins of about 30%. Six are based in the sUSA and four are based in Europe. North and South America, Europe, and Japan are expected to continue to account for a complete 85% of the global pharmaceutical market well into the 21st century. At present, businesses spend one-third of their sales income on selling their goods - nearly double what they spend on research and growth.

Atsiliepimai

  • Atsiliepimų nėra
0 pirkėjai įvertino šią prekę.
5
0%
4
0%
3
0%
2
0%
1
0%
(rodomas nebus)